The stem cell factor, its properties and potential role in the airways

Pulmonary Pharmacology and Therapeutics

Volumn 14, Issue 4, 2001, Pages 277-288

  Kassel, Olivier ^a   Da Silva, Carla ^a   Frossard, Nelly ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

AIRWAY; CELL ACTIVATION; CELL ADHESION; CELL COUNT; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; CHROMOSOME 12Q; HEMATOPOIESIS; HUMAN; MAST CELL; MAST CELL DEGRANULATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034942924     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.2001.0304     Document Type: Review

References (159)

1. The hematopoietic growth factor KL is encoded by the S1 locus and is the ligand of the c-Kit receptor, the gene product of the W locus
2. Primary structure and functional expression of rat and human stem cell factor DNAs
3. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-Kit tyrosine kinase receptor
4. The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells
5. Role of c-Kit ligand in the expansion of human hematopoietic progenitor cells
6. Stem cell factor and hematopoiesis
7. The kit ligand, stem cell factor
8. New insights into "The riddle of mast cells": Microenvironmental regulation of mast cell development and phenotypic heterogeneity
9. Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-Kit receptor
10. + pluripotent progenitor cells
11. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+ Fc(epsilon)RI(-) cell population
12. Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells
13. Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-Kit+, and expresses aminopeptidase N (CD13)
14. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3
15. The c-Kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis
16. The c-Kit receptor ligand functions as a mast cell chemoattractant
17. Stem cell factor is a chemotactic factor for human mast cells
18. Stem cell factor induces mast cell adhesion to fibronectin
19. Steel factor and c-Kit regulate celt-matrix adhesion
20. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant
21. Necessity of extracellular domain of W (c-Kit) receptors for attachment of murine culture mast cells to fibroblasts
22. Inhibition of attachment between cultured mast cells and fibroblasts by phorbol 12-myristate 13-acetate and stem cell factor
23. Recombinant human stem cell factor (Kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo
24. Ultrastructural analysis of human skin biopsy specimens from patients receiving recombinant human stem cell factor: Subcutaneous injection of rhSCF induces dermal mast cell degranulation and granulocyte recruitment at the injection site
25. c-Kit ligand: A unique potentiator of mediator release by human lung mast cells
26. Assessment of the anti-c-Kit monoclonal antibody YB5.B8 in affinity magnetic enrichment of human lung mast cells
27. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils
28. Effect of cytokines on mediator release from human dispersed lung mast cells
29. Dexamethasone or cyclosporin A inhibits stem cell factor-dependent secretory responses of rat peritoneal mast cells in vitro
30. The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function
31. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells
32. Inflammatory cells in the airways in mild asthma
33. Cellular events in the bronchi in mild asthma and after bronchial provocation
34. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry
35. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
36. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation
37. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate
38. Airway mucosal inflammation even in patients with newly diagnosed asthma
39. Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects
40. Interleukin-4, interleukin-5, and interleukin-6 and tumor necrosis factor-alpha in normal and asthmatic airways - Evidence for the human mast cell as a source of these cytokines
41. Airway basophil and mast cell density in patients with bronchial asthma: Relationship to bronchial hyperresponsiveness
42. Human peripheral blood eosinophils express a functional c-Kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule & (VCAM-1)
43. Alternate splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-q24
44. Glycosylated and unglycosylated recombinant-derived human stem cell factors are dimeric and have extensive regular secondary structures
45. Spontaneous dissociation-association of monomers of the human-stem-cell-factor dimer
46. Structure of the active core of human stem cell factor and analysis of binding to its receptor kit
47. Crystal structure of human stem cell factor: Implication for stem cell factor receptor dimerization and activation
48. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor
49. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells
50. Chymase cleavage of stem cell factor yields a bioactive soluble product
51. Novel autocrine and paracrine loops of the stem cell factor/chymase network
52. Airway epithelial cells produce stem cell factor
53. Cytokine production by cell cultures from bronchial subepithelial myofibroblasts
54. Up- and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor SCF by human lung fibroblasts in culture
55. Human bronchial smooth muscle cells in culture produce stem cell factor
56. Human mast cells express stem cell factor
57. Stem cell factor is localized in, released from, and cleaved by human mast cells
58. Human mast cells produce and differentially express both soluble and membrane-bound stem cell factor
59. Tumor necrosis factor α promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis
60. Constitutive expression of steel factor gene by human stromal cells
61. Expression of stem cell factor and c-Kit in allergic asthma
62. Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand
63. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus
64. The dominant-white spotting (W) locus of the mouse encodes the c-kit protooncogene
65. Primary structure of c-kit: Relationship to the CSF-1/PDGF receptor kinase family - Oncogenic activation of v-kit involves deletion of extracellular domain and C terminus
66. Inhibition of spontaneous receptor phosphorylation by residues in a putative α-helix in the kit intracellular juxtamembrane region
67. Human umbilical vein endothelial cells display high-affinity c-Kit receptors and produce a soluble form of the c-Kit receptor
68. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mice - Evidence for an impaired c-kit kinase in mutant mice
69. Expression and function of c-Kit in hemopoietic progenitor cells
70. Expression of stem cell factor and c-Kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF)
71. Isolation and characterization of a monoclonal antibody that recognizes the human c-Kit receptor
72. Phenotypic and functional characterization of c-Kit expression during intrathymic T cell development
73. Gonadal expression of c-kit encoded at the W locus of the mouse
74. Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues
75. Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis
76. The Steel/W transduction pathway: Kit autophosphorylation and its association with a unique subset of cytoplasmic signalling proteins is induced by the Steel factor
77. The ubiquitously expressed Syp phosphatase interacts with c-Kit and Grb2 in hematopoietic cells
78. Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor
79. Socsl binds to multiple signaling proteins and suppresses Steel factor-dependent proliferation
80. Steel factor stimulates the tyrosine phosphorylation of the proto-oncogen product, p95vav, in human hemopoietic cells
81. SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain
82. Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors
83. Comparative analysis of signaling pathways between mast cell growth factor (c-Kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase
84. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas
85. Steel factor-induced tyrosine phosphorylation in murine mast cells. Common elements with IL-3-induced signal transduction pathways
86. p21ras activation via hemopoietin receptors and c-Kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein
87. Granulocyte-macrophage colony-stimulating factor and steel factor induce phosphorylation of both unique and overlapping signal transduction intermediates in a human factor-dependent hematopoietic cell line
88. Mitogen-activated protein kinase activation through Fcε receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells
89. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells
90. Erythropoietin-and stem cell factor-induced DNA synthesis in normal human erythroid progenitor cells requires activation of protein kinase Cα and is strongly inhibited by thrombin
91. Phosphatidylinositol 3′-kinase associates with p145c-Kit as part of a cell type characteristic miltimeric signalling complex
92. Synergistic activation of MAP Kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis
93. Isoforms of c-Kit differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts
94. Tec kinase associates with c-Kit and is tyrosine phosphorylated and activated following stem cell factor binding
95. Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells
96. Lck associates with and is activated by Kit in a small cell lung cancer cell line: Inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1
97. Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinase
98. Stat 1 associates with c-Kit and is activated in response to stem cell factor
99. JAK2 is associated with the c-Kit proto-oncogene product and is phosphorylated in response to stem cell factor
100. STAT protein recruitment and activation in c-Kit deletion mutants
101. Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase C-gamma 1 pathways
102. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells
103. Kit signaling through PI 3-kinase and Src kinase pathways: An essential role for Racl and JNK activation in mast cell proliferation
104. Stem cell factor/c-Kit up-regulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase pathway in spermatogonia
105. Lyn is activated during late G1 of stem-cell-factor-induced cell cycle progression in haemopoietic cells
106. Distinct paterns of early response gene expression and proliferation in mouse mast cells stimulated by stem cell factor, interleukin-3, or IgE and antigen
107. Stem cell factor activates STAT-5 DNA binding in IL-3 derived bone marrow mast cells
108. Tyrosine kinase-deficient Wv c-Kit induces mast cell adhesion and chemotaxis
109. Inhibition of stem cell factor-and nerve growth factor-induced morphological change by wortmannin in mast cells
110. Signaling via Src family kinases is required for normal internalization of the receptor c-Kit
111. Stromal cell-derived factor-1 alpha and stem cell factor/kit ligand share signaling pathways in hemopoietic progenitors: A potential mechanism for cooperative induction of chemotaxis
112. The Kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136
113. Aggregation of the FcepsilonRI on mast cells stimulates c-Jun amino-terminal kinase activity. A response inhibited by wortmannin
114. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells
115. c-Kit receptor signaling through its phosphatidylinositide-3′-kinase-binding site and protein kinase C: Role in mast cell enhancement of degranulation, adhesion, and membrane ruffling
116. Targeted disruption of SHIP leads to steel factor-induced degranulation of mast cells
117. Primitive myeloid cells express high levels of phospholipase A2 activity in the absence of leukotriene release: Selective regulation by stem cell factor involving the MAP Kinase pathway
118. Analysis of c-Kit receptor dimerization by fluorescence resonance energy transfer
119. Basophils and mast cells in airway inflammation and asthma
120. Mast cells in asthma
121. New concepts: The basophil
122. The cellular and mediator basis of asthma in relation to natural history
123. Eosinophils and eosinophil-associated cytokines in allergic inflammation
124. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long term culture
125. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-Kit ligand
126. Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4
127. Selective growth of human mast cells induced by steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells
128. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation
129. Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro
130. Steel-Dickie mutation encodes a c-Kit ligand lacking transmembrane and cytoplasmic domains
131. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: Basis for radiosensitivity of White spotting and Steel mutant mice
132. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-Kit ligand, stem cell factor, by resident cells - In vitro and in vivo evidence in murine systems
133. Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cells
134. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma
135. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma
136. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial
137. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma
138. Prednisolone treatment in asthma. Reduction in the number of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokin gene expression within the bronchial mucosa
139. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation
140. Effect of short-term treatment with low-dose inhaled fluticasone-propionate on airway inflammation and remodeling in mild asthma: A placebo-controlled study
141. Demonstration of mast cell chemotactic activity in bronchoalveolar lavage fluid collected from asthmatic patients before and during pollen season
142. Demonstration of mast-cell chemotactic activity in nasal lavage fluid: Characterization of one chemotaxin as c-Kit ligand, stem cell factor
143. Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-Kit receptor activation
144. Expression of SCF splice variants in human melanocytes and melanoma cell lines: Potential prognostic implications
145. Recombinant stem cell factor-induced mast cell activation and smooth muscle contraction in human bronchi
146. Diamine oxidase-gold ultrastructural localization of histamine in human skin biopsies containing mast cells stimulated to degranulate in vivo by exposure to recombinant human stem cell factor
147. Human lung mast cells are enriched in the capacity to produce granulocyte-macrophage colony-stimulating factor in response to IgE-dependent stimulation
148. Stem cell factor-deficient mice have a dysregulation of cytokine production during local inflammation
149. Differential release of mast cell interleukin-6 via c-Kit
150. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions
151. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family
152. -, colony forming cell
153. Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils
154. Soluble stem cell factor in human serum
155. The role of stem cell factor (c-Kit ligand) and inflammatory cytokines in pulmonary mast cell activation
156. Stem cell factor in nasal polyposis and allergic rhinitis: Increased expression by structural cells is suppressed by in vivo topical corticosteroids
157. Stem cell factor mRNA expression and production in human nasal epithelial cells: Contribution to the accumulation of mast cells in nasal epithelium of allergy
158. Stem cell factor-induced airway hyperreactivity in allergic and normal mice
159. Stem cell factor plays a major role in the recruitment of eosinophils in allergic pleuridy in mice via the production of leukotriene B4